|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 22 found articles
| Title: |
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial |
| Author: |
Sandborn, William J Panés, Julian Danese, Silvio Sharafali, Zaineb Hassanali, Azra Jacob-Moffatt, Rhian Eden, Christopher Daperno, Marco Valentine, John F Laharie, David Baía, Carolina Atreya, Raja Panaccione, Remo Rydzewska, Grazyna Aguilar, Humberto Vermeire, Séverine |
| Appeared in: |
The Lancet gastroenterology & hepatology |
| Paging: | Volume 8 () nr. 1 pages 43-55 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 22 found articles
| << previous | next >> |